142 related articles for article (PubMed ID: 38189855)
21. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
[TBL] [Abstract][Full Text] [Related]
22. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma.
Liu Y; Shi M; He X; Cao Y; Liu P; Li F; Zou S; Wen C; Zhan Q; Xu Z; Wang J; Sun B; Shen B
J Hematol Oncol; 2022 May; 15(1):52. PubMed ID: 35526050
[TBL] [Abstract][Full Text] [Related]
24. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
25. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
[TBL] [Abstract][Full Text] [Related]
26. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma.
Shen H; Ye F; Xu D; Fang L; Zhang X; Zhu J
Cell Death Dis; 2021 Dec; 13(1):15. PubMed ID: 34930894
[TBL] [Abstract][Full Text] [Related]
27. A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma.
Zhou C; Zhao Y; Yin Y; Hu Z; Atyah M; Chen W; Meng Z; Mao H; Zhou Q; Tang W; Wang P; Li Z; Weng J; Bruns C; Popp M; Popp F; Dong Q; Ren N
Int J Biol Sci; 2019; 15(11):2282-2295. PubMed ID: 31595147
[TBL] [Abstract][Full Text] [Related]
28. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
30. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.
Hermano E; Meirovitz A; Meir K; Nussbaum G; Appelbaum L; Peretz T; Elkin M
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326645
[TBL] [Abstract][Full Text] [Related]
31. Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma.
Li TJ; Li H; Zhang WH; Xu SS; Jiang W; Li S; Gao HL; Han X; Xu HX; Wu CT; Wang WQ; Yu XJ; Liu L
Int J Cancer; 2021 Apr; 148(7):1756-1767. PubMed ID: 33236361
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
33. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
[TBL] [Abstract][Full Text] [Related]
34. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization.
Chandrakesan P; Panneerselvam J; May R; Weygant N; Qu D; Berry WR; Pitts K; Stanger BZ; Rao CV; Bronze MS; Houchen CW
Mol Cancer Ther; 2020 Jul; 19(7):1539-1549. PubMed ID: 32371580
[TBL] [Abstract][Full Text] [Related]
35. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
[TBL] [Abstract][Full Text] [Related]
37. Development and Verification of a novel cuproptosis- and immune-associated based prognostic genetic signature for pancreatic ductal adenocarcinoma.
Xu X; Liang JH; Xu QC; Yin XY
Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102089. PubMed ID: 36707046
[TBL] [Abstract][Full Text] [Related]
38. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
Sun L; Zhang X; Song Q; Liu L; Forbes E; Tian W; Zhang Z; Kang Y; Wang H; Fleming JB; Pasche BC; Zhang W
Cancer Lett; 2021 Mar; 500():132-146. PubMed ID: 33309859
[TBL] [Abstract][Full Text] [Related]
39. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
[TBL] [Abstract][Full Text] [Related]
40. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]